PATENT CLAIM ANALYSIS

Application Number: 16067490
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-01
Patent Classification: ["544", "344000"]

Abstract:
Described are positive allosteric modulators of the GLP-1 receptor, pharmaceutical compositions including the compounds, and methods of using the compounds and compositions for diabetes mellitus type 2, obesity, depression, Alzheimer's disease, Parkinson's disease, Huntington's disease, stroke, cognitive dysfunction, learning disability, and asthma in a subject.

Claim (Index 28):
A pharmaceutical composition comprising the compound of any one of  claims 1 - 27  and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 97.0
- Lexical Diversity: 1.53846
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15006486', '11510451', '13469021', '12390286', '15661582']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7582182298618484
- 35 USC 102 Novelty (BERT): 0.5303661306636284
- Combined Prediction Score: 0.7354330199420265
- Mean Citation Score: 339.47541600000005
- Max Citation Score: 352.13074
- Similarity Product: 252.4957934863424

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test